The Role of FADD in Pancreatic Cancer Cell Proliferation and Drug Resistance

Overview

Journal Oncol Lett

Specialty Oncology

Date 2017 Apr 30

PMID 28454341

Citations 10

Authors

Rong Zhang

Yingting Liu

Kahina Hammache

Liangqiang He

Bo Zhu

Wei Cheng

Zi-Chun Hua

Affiliations

Soon will be listed here.

Abstract

Pancreatic cancer has one of the poorest patient outcomes and is highly resistant to chemotherapy. Identifying the molecular mechanisms involved in drug resistance is critical in the development of novel strategies to treat pancreatic cancer. The results of the present study demonstrate that Fas-associated death domain protein (FADD), a classical adaptor protein mediating apoptotic stimuli-induced cell death, protects pancreatic cancer cells from drug-induced apoptosis. In contrast to its classical apoptotic roles, it was observed that FADD is required for pancreatic cancer cell proliferation and that it is overexpressed to varying degrees in various types of pancreatic cancer cell. This leads to differing levels of drug resistance in pancreatic cancer cells, where drug resistance is positively correlated with FADD expression. Notably, the results of the present study demonstrate that FADD protects pancreatic cancer cells from drug-induced apoptosis, while RNA interference of FADD sensitizes drug-resistant cells to Adriamycin-mediated apoptosis. The results of the present study reveal unexpected roles for FADD in pancreatic cancer cell proliferation and drug resistance.

Citing Articles

Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.

Yang P, Huang G, Li Y, Yu L, Yin Z, Li Q Sci Rep. 2024; 14(1):9824.

PMID: 38684755 PMC: 11058810. DOI: 10.1038/s41598-024-60441-8.

FADD as a key molecular player in cancer progression.

Liu Y, Li X, Zhou X, Wang J, Ao X Mol Med. 2022; 28(1):132.

PMID: 36348274 PMC: 9644706. DOI: 10.1186/s10020-022-00560-y.

Heterogeneous genomic aberrations in esophageal squamous cell carcinoma: a review.

Li R, Li P, Xing W, Qiu H Am J Transl Res. 2020; 12(5):1553-1568.

PMID: 32509161 PMC: 7269976.

Knock down of Fas-Associated Protein with Death Domain (FADD) Sensitizes Osteosarcoma to TNFα-induced Cell Death.

Hollomon M, Patterson L, Santiago-OFarrill J, Kleinerman E, Gordon N J Cancer. 2020; 11(7):1657-1667.

PMID: 32194778 PMC: 7052864. DOI: 10.7150/jca.38721.

Association between ANGPTL-4 and the proinflammatory process in cancer cachexia patients.

Neto N, Boldarine V, Hachul A, Oyama L, Darck Carola Correia Lima J, Fernandez E Oncotarget. 2019; 10(60):6444-6455.

PMID: 31741709 PMC: 6849656. DOI: 10.18632/oncotarget.27269.

References

King K, Cidlowski J . Cell cycle regulation and apoptosis. Annu Rev Physiol. 1998; 60:601-17. DOI: 10.1146/annurev.physiol.60.1.601. View

Zhang H, Zhou X, McQuade T, Li J, Chan F, Zhang J . Functional complementation between FADD and RIP1 in embryos and lymphocytes. Nature. 2011; 471(7338):373-6. PMC: 3072026. DOI: 10.1038/nature09878. View

Chinnaiyan A, ORourke K, Tewari M, Dixit V . FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995; 81(4):505-12. DOI: 10.1016/0092-8674(95)90071-3. View

Cheng W, Wang L, Yang B, Zhang R, Yao C, He L . Self-renewal and differentiation of muscle satellite cells are regulated by the Fas-associated death domain. J Biol Chem. 2013; 289(8):5040-50. PMC: 3931063. DOI: 10.1074/jbc.M113.533448. View

Zhang J, Winoto A . A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis. Mol Cell Biol. 1996; 16(6):2756-63. PMC: 231266. DOI: 10.1128/MCB.16.6.2756. View

Yeh W, de la Pompa J, McCurrach M, Shu H, Elia A, Shahinian A . FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 1998; 279(5358):1954-8. DOI: 10.1126/science.279.5358.1954. View

Tourneur L, Delluc S, Levy V, Valensi F, Radford-Weiss I, Legrand O . Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome. Cancer Res. 2004; 64(21):8101-8. DOI: 10.1158/0008-5472.CAN-04-2361. View

Andren-Sandberg A . Pancreatic cancer: chemotherapy and radiotherapy. N Am J Med Sci. 2012; 3(1):1-12. PMC: 3336926. DOI: 10.4297/najms.2011.31. View

Welz P, Wullaert A, Vlantis K, Kondylis V, Fernandez-Majada V, Ermolaeva M . FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature. 2011; 477(7364):330-4. DOI: 10.1038/nature10273. View

10.

Alappat E, Feig C, Boyerinas B, Volkland J, Samuels M, Murmann A . Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities. Mol Cell. 2005; 19(3):321-32. DOI: 10.1016/j.molcel.2005.06.024. View

11.

Chen G, Bhojani M, Heaford A, Chang D, Laxman B, Thomas D . Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci U S A. 2005; 102(35):12507-12. PMC: 1194899. DOI: 10.1073/pnas.0500397102. View

12.

Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View

13.

Kuang A, Diehl G, Zhang J, Winoto A . FADD is required for DR4- and DR5-mediated apoptosis: lack of trail-induced apoptosis in FADD-deficient mouse embryonic fibroblasts. J Biol Chem. 2000; 275(33):25065-8. DOI: 10.1074/jbc.C000284200. View

14.

Osborn S, Diehl G, Han S, Xue L, Kurd N, Hsieh K . Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proc Natl Acad Sci U S A. 2010; 107(29):13034-9. PMC: 2919948. DOI: 10.1073/pnas.1005997107. View

15.

Gibcus J, Menkema L, Mastik M, Hermsen M, de Bock G, van Velthuysen M . Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin Cancer Res. 2007; 13(21):6257-66. DOI: 10.1158/1078-0432.CCR-07-1247. View

16.

Kwek S, Roy R, Zhou H, Climent J, Martinez-Climent J, Fridlyand J . Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis. Oncogene. 2009; 28(17):1892-903. PMC: 2722962. DOI: 10.1038/onc.2009.34. View

17.

Newton K, Harris A, Strasser A . FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor. EMBO J. 2000; 19(5):931-41. PMC: 305633. DOI: 10.1093/emboj/19.5.931. View

18.

Kabra N, Kang C, Hsing L, Zhang J, Winoto A . T cell-specific FADD-deficient mice: FADD is required for early T cell development. Proc Natl Acad Sci U S A. 2001; 98(11):6307-12. PMC: 33464. DOI: 10.1073/pnas.111158698. View

19.

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1):10-29. DOI: 10.3322/caac.20138. View

20.

Chinnaiyan A, Tepper C, Seldin M, ORourke K, Kischkel F, Hellbardt S . FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem. 1996; 271(9):4961-5. DOI: 10.1074/jbc.271.9.4961. View